Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ARHGAP42 RALGAPA1 ARHGAP32 DOCK11 DOCK8 SIPA1L1 SIPA1L3 AGFG1	3.51e-04	507	69	8	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ARHGAP42 RALGAPA1 ARHGAP32 DOCK11 DOCK8 SIPA1L1 SIPA1L3 AGFG1	3.51e-04	507	69	8	GO:0030695
GeneOntologyMolecularFunction	GTPase activator activity	ARHGAP42 RALGAPA1 ARHGAP32 SIPA1L1 SIPA1L3 AGFG1	4.04e-04	279	69	6	GO:0005096
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity	MTMR14 MTMR2	6.34e-04	11	69	2	GO:0052629
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA3 NCOA1	8.17e-04	53	69	3	GO:0030331
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate phosphatase activity	MTMR14 MTMR2	1.04e-03	14	69	2	GO:0004438
GeneOntologyMolecularFunction	phosphatidylinositol monophosphate phosphatase activity	MTMR14 MTMR2	1.20e-03	15	69	2	GO:0052744
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA2 NCOA3 NCOA1	1.23e-03	61	69	3	GO:0030374
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	MTMR14 MTMR2	1.37e-03	16	69	2	GO:0106018
GeneOntologyBiologicalProcess	rhythmic process	NCOA2 SP1 OXTR KCNMA1 PHLPP1 NCOA1 PLEKHA1 GRIN3A	2.64e-05	360	69	8	GO:0048511
GeneOntologyBiologicalProcess	cellular response to Thyroglobulin triiodothyronine	NCOA2 NCOA1	6.59e-05	4	69	2	GO:1904017
GeneOntologyBiologicalProcess	positive regulation of female receptivity	NCOA2 NCOA1	6.59e-05	4	69	2	GO:0045925
HumanPheno	Pulmonary artery sling	SMG8 ZEB2	1.46e-05	2	20	2	HP:0004961
Domain	DUF1518	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	PF07469
Domain	DUF1518	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	IPR010011
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	IPR014920
Domain	SRC-1	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	IPR014935
Domain	Src1_rcpt_coact	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	IPR017426
Domain	DUF1518	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	SM01151
Domain	SRC-1	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	PF08832
Domain	-	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	4.10.630.10
Domain	Nuc_rec_co-act	NCOA2 NCOA3 NCOA1	4.83e-08	3	69	3	PF08815
Domain	Nuc_rcpt_coact	NCOA2 NCOA3 NCOA1	9.58e-07	6	69	3	IPR009110
Domain	Rap_GAP	RALGAPA1 SIPA1L1 SIPA1L3	5.68e-06	10	69	3	PF02145
Domain	Rap_GAP_dom	RALGAPA1 SIPA1L1 SIPA1L3	7.80e-06	11	69	3	IPR000331
Domain	RAPGAP	RALGAPA1 SIPA1L1 SIPA1L3	7.80e-06	11	69	3	PS50085
Domain	DUF4927	NCOA2 NCOA3	1.35e-05	2	69	2	PF16279
Domain	DUF4927	NCOA2 NCOA3	1.35e-05	2	69	2	IPR032565
Domain	DUF3697	UBAP2 UBAP2L	1.35e-05	2	69	2	PF12478
Domain	DUF3697_Uba2	UBAP2 UBAP2L	1.35e-05	2	69	2	IPR022166
Domain	SPAR_C	SIPA1L1 SIPA1L3	4.03e-05	3	69	2	PF11881
Domain	SIPA1L_C	SIPA1L1 SIPA1L3	4.03e-05	3	69	2	IPR021818
Domain	PAS	NCOA2 NCOA3 NCOA1	1.05e-04	25	69	3	PF00989
Domain	PAS_fold	NCOA2 NCOA3 NCOA1	1.05e-04	25	69	3	IPR013767
Domain	DUF3398	DOCK11 DOCK8	2.00e-04	6	69	2	PF11878
Domain	DOCK_C/D_N	DOCK11 DOCK8	2.00e-04	6	69	2	IPR021816
Domain	PAS	NCOA2 NCOA3 NCOA1	2.22e-04	32	69	3	SM00091
Domain	PAS	NCOA2 NCOA3 NCOA1	2.66e-04	34	69	3	IPR000014
Domain	PAS	NCOA2 NCOA3 NCOA1	2.66e-04	34	69	3	PS50112
Domain	LAM_G_DOMAIN	CELSR1 CELSR3 CNTNAP4	3.71e-04	38	69	3	PS50025
Domain	Laminin_G_2	CELSR1 CELSR3 CNTNAP4	4.32e-04	40	69	3	PF02210
Domain	LamG	CELSR1 CELSR3 CNTNAP4	5.73e-04	44	69	3	SM00282
Domain	-	ARHGAP42 DOCK11 IPCEF1 MTMR2 PHLPP1 PLEKHA1 TNS4	5.90e-04	391	69	7	2.30.29.30
Domain	-	NCOA2 NCOA3 NCOA1 FIGLA	7.09e-04	109	69	4	4.10.280.10
Domain	GAIN_dom_N	CELSR1 CELSR3	7.24e-04	11	69	2	IPR032471
Domain	DOCK_C	DOCK11 DOCK8	7.24e-04	11	69	2	IPR010703
Domain	DHR-1_domain	DOCK11 DOCK8	7.24e-04	11	69	2	IPR027007
Domain	DHR_2	DOCK11 DOCK8	7.24e-04	11	69	2	PS51651
Domain	DHR_1	DOCK11 DOCK8	7.24e-04	11	69	2	PS51650
Domain	DOCK-C2	DOCK11 DOCK8	7.24e-04	11	69	2	PF14429
Domain	DHR-2	DOCK11 DOCK8	7.24e-04	11	69	2	IPR027357
Domain	DHR-2	DOCK11 DOCK8	7.24e-04	11	69	2	PF06920
Domain	GAIN	CELSR1 CELSR3	7.24e-04	11	69	2	PF16489
Domain	DOCK	DOCK11 DOCK8	7.24e-04	11	69	2	IPR026791
Domain	Znf_C2H2_matrin	MATR3 ZNF318	8.67e-04	12	69	2	IPR000690
Domain	HLH	NCOA2 NCOA3 NCOA1 FIGLA	8.95e-04	116	69	4	SM00353
Domain	BHLH	NCOA2 NCOA3 NCOA1 FIGLA	9.24e-04	117	69	4	PS50888
Domain	bHLH_dom	NCOA2 NCOA3 NCOA1 FIGLA	9.54e-04	118	69	4	IPR011598
Domain	PH_dom-like	ARHGAP42 DOCK11 IPCEF1 MTMR2 PHLPP1 PLEKHA1 TNS4	9.76e-04	426	69	7	IPR011993
Domain	Laminin_G	CELSR1 CELSR3 CNTNAP4	1.29e-03	58	69	3	IPR001791
Domain	PH	ARHGAP42 DOCK11 IPCEF1 PHLPP1 PLEKHA1	1.58e-03	229	69	5	PF00169
Domain	UBA-like	UBAP2 UBAP2L TNRC6B	1.71e-03	64	69	3	IPR009060
Domain	ZF_MATRIN	MATR3 ZNF318	1.98e-03	18	69	2	PS50171
Domain	PH	ARHGAP42 DOCK11 IPCEF1 PHLPP1 PLEKHA1	3.65e-03	278	69	5	SM00233
Domain	PH_DOMAIN	ARHGAP42 DOCK11 IPCEF1 PHLPP1 PLEKHA1	3.70e-03	279	69	5	PS50003
Domain	PH_domain	ARHGAP42 DOCK11 IPCEF1 PHLPP1 PLEKHA1	3.76e-03	280	69	5	IPR001849
Domain	HormR	CELSR1 CELSR3	3.82e-03	25	69	2	SM00008
Domain	HRM	CELSR1 CELSR3	4.78e-03	28	69	2	PF02793
Domain	ZnF_U1	MATR3 ZNF318	5.12e-03	29	69	2	SM00451
Domain	Znf_U1	MATR3 ZNF318	5.12e-03	29	69	2	IPR003604
Domain	-	CELSR1 CELSR3 CNTNAP4	5.24e-03	95	69	3	2.60.120.200
Domain	EGF_LAM_2	CELSR1 CELSR3	5.47e-03	30	69	2	PS50027
Domain	EGF_LAM_1	CELSR1 CELSR3	5.47e-03	30	69	2	PS01248
Domain	UBA	UBAP2 UBAP2L	5.47e-03	30	69	2	SM00165
Domain	GPS	CELSR1 CELSR3	6.99e-03	34	69	2	SM00303
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA2 NCOA3 NCOA1	9.07e-06	11	55	3	M47503
Pathway	PID_ERB_GENOMIC_PATHWAY	NCOA2 NCOA3 NCOA1	2.47e-05	15	55	3	M119
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	NCOA2 NCOA3 SP1 NCOA1 ZNF318	2.71e-05	91	55	5	M39700
Pathway	KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA3 NCOA1	1.48e-04	5	55	2	M48983
Pathway	PID_RETINOIC_ACID_PATHWAY	NCOA2 NCOA3 NCOA1	2.12e-04	30	55	3	M207
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	NCOA2 SP1 NCOA1	2.34e-04	31	55	3	M39476
Pathway	WP_PREGNANE_X_RECEPTOR_PATHWAY	NCOA2 NCOA3 NCOA1	2.57e-04	32	55	3	M39567
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	SP1 TNRC6B ZEB2	2.57e-04	32	55	3	M48012
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	NCOA2 NCOA3 SP1 NCOA1 TNRC6B	2.80e-04	149	55	5	M27888
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ARHGAP42 ARHGAP32 DOCK11 DOCK8	4.87e-04	94	55	4	MM15598
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	NCOA2 SP1 NCOA1	5.79e-04	42	55	3	M27172
Pathway	REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION	SP1 ZEB2	6.59e-04	10	55	2	M48016
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	NCOA2 RNF2 NCOA1	6.65e-04	44	55	3	M27295
Pathway	REACTOME_REGULATION_OF_CDH11_EXPRESSION_AND_FUNCTION	SP1 ZEB2	9.62e-04	12	55	2	MM17071
Pathway	KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2	YAF2 RNF2	9.62e-04	12	55	2	M47943
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 NCOA3 SP1 NCOA1	1.14e-03	118	55	4	M27316
Pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	MTMR14 MTMR2 PLEKHA1	1.15e-03	53	55	3	M662
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NCOA2 SP1 NCOA1	1.28e-03	55	55	3	M27001
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL	NCOA2 NCOA1	1.32e-03	14	55	2	M27074
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL	NCOA2 NCOA1	1.32e-03	14	55	2	MM14748
Pathway	WP_NUCLEAR_RECEPTORS_METAPATHWAY	NCOA2 NCOA3 SP1 NCOA1 TNS4 SEC14L1	1.35e-03	314	55	6	M39428
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	SP1 TNRC6B ZEB2	1.49e-03	58	55	3	M11980
Pathway	REACTOME_RHO_GTPASE_CYCLE	ARHGAP42 RALGAPA1 CCP110 ARHGAP32 DOCK11 DOCK8 RBBP6	1.51e-03	439	55	7	MM15595
Pathway	KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27	YAF2 RNF2	1.52e-03	15	55	2	M47973
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	NCOA2 NCOA3 SP1 NCOA1 TNRC6B	1.63e-03	220	55	5	M27794
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC12 MUC6	1.73e-03	16	55	2	M27410
Pathway	REACTOME_RHOJ_GTPASE_CYCLE	ARHGAP32 DOCK8	1.73e-03	16	55	2	MM15605
Pathway	REACTOME_RHO_GTPASE_CYCLE	ARHGAP42 RALGAPA1 CCP110 ARHGAP32 DOCK11 DOCK8 RBBP6	1.74e-03	450	55	7	M27078
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	NCOA2 SP1 NCOA1	1.89e-03	63	55	3	MM15613
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC12 MUC6	1.96e-03	17	55	2	M27412
Pathway	PID_ERA_GENOMIC_PATHWAY	NCOA2 NCOA3 NCOA1	1.98e-03	64	55	3	M200
Pathway	PID_HIF1_TFPATHWAY	NCOA2 SP1 NCOA1	2.16e-03	66	55	3	M255
Pathway	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	NCOA2 NCOA1	2.20e-03	18	55	2	M4862
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 NCOA1	2.20e-03	18	55	2	MM15034
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA2 NCOA1	2.20e-03	18	55	2	M26942
Pathway	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	NCOA2 NCOA1	2.45e-03	19	55	2	MM14612
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ARHGAP42 ARHGAP32 DOCK11 DOCK8	3.10e-03	155	55	4	M41808
Pathway	REACTOME_CELL_CELL_COMMUNICATION	SP1 KIRREL3 TNRC6B ZEB2	3.10e-03	155	55	4	M522
Pathway	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119	YAF2 RNF2	3.28e-03	22	55	2	M47924
Pathway	REACTOME_PI_METABOLISM	MTMR14 MTMR2 PLEKHA1	3.35e-03	77	55	3	MM14590
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	ARHGAP42 NCOA2 RALGAPA1 CCP110 ARHGAP32 DOCK11 DOCK8 RBBP6	3.47e-03	649	55	8	MM15690
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC12 MUC6	3.59e-03	23	55	2	M556
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	NCOA2 NCOA1	3.59e-03	23	55	2	M1926
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	NCOA2 NCOA1	3.59e-03	23	55	2	MM14741
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	NCOA2 SP1 NCOA1	4.00e-03	82	55	3	M2
Pathway	REACTOME_ENDOGENOUS_STEROLS	NCOA2 NCOA1	4.23e-03	25	55	2	M11184
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6	YAF2 RNF2	4.23e-03	25	55	2	MM15546
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOA2 NCOA3 NCOA1	4.28e-03	84	55	3	M1008
Pathway	REACTOME_PI_METABOLISM	MTMR14 MTMR2 PLEKHA1	4.28e-03	84	55	3	M676
Pathway	REACTOME_DECTIN_2_FAMILY	MUC12 MUC6	4.57e-03	26	55	2	M27483
Pathway	REACTOME_RAC1_GTPASE_CYCLE	ARHGAP42 ARHGAP32 DOCK11 DOCK8	4.78e-03	175	55	4	MM15599
Pathway	REACTOME_ENDOGENOUS_STEROLS	NCOA2 NCOA1	4.93e-03	27	55	2	MM14844
Pathway	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES	YAF2 RNF2	4.93e-03	27	55	2	M47941
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA2 NCOA1	4.93e-03	27	55	2	M26943
Pubmed	Human transcription factor protein interaction networks.	RLF HMBOX1 NCOA2 EPC2 NCOA3 SP1 ARHGAP32 UBAP2 YAF2 RNF2 RBBP6 UBAP2L ATXN7L1 ZNF644 MATR3 OTUD4 NCOA1 TNRC6B MLLT6 SCAF11 ZNF318 QSER1 HRNR ZEB2	2.53e-16	1429	70	24	35140242
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TAOK2 NCOA2 NCOA3 ARHGAP32 UBAP2 DOCK11 UBAP2L SIPA1L1 MATR3 SIPA1L3 KCNMA1 OTUD4 TNRC6B ZNF318 QSER1 ZEB2	6.46e-11	963	70	16	28671696
Pubmed	Interaction network of human early embryonic transcription factors.	RLF NCOA2 EPC2 NCOA3 HIVEP2 ZNF644 NCOA1 QSER1 HRNR ZEB2	2.24e-09	351	70	10	38297188
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	HAUS6 RBBP6 SIPA1L1 SIPA1L3 TNRC6B ZNF318 HRNR ZEB2	3.76e-09	184	70	8	32908313
Pubmed	The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	21035760
Pubmed	Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	21059860
Pubmed	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	16675958
Pubmed	Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	9506940
Pubmed	Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	28390937
Pubmed	Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	23927929
Pubmed	Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	18845648
Pubmed	The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	12138202
Pubmed	Structure and chromosomal locations of mouse steroid receptor coactivator gene family.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	10501088
Pubmed	The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.	NCOA2 NCOA3 NCOA1	7.81e-09	3	70	3	16423883
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TAOK2 ARHGAP32 CELSR3 UBAP2L ATXN7L1 SIPA1L1 CNTNAP4	8.54e-09	130	70	7	12421765
Pubmed	EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis.	YAF2 RNF2 UBAP2L OTUD4 QSER1	2.92e-08	44	70	5	27505670
Pubmed	miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.	NCOA2 NCOA3 NCOA1	3.12e-08	4	70	3	26066330
Pubmed	P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.	NCOA2 NCOA3 NCOA1	3.12e-08	4	70	3	18267973
Pubmed	Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.	NCOA2 NCOA3 NCOA1	3.12e-08	4	70	3	15331759
Pubmed	Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.	NCOA2 NCOA3 NCOA1	3.12e-08	4	70	3	19095746
Pubmed	Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.	NCOA2 NCOA3 NCOA1	3.12e-08	4	70	3	22560224
Pubmed	Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.	NCOA2 NCOA3 NCOA1	3.12e-08	4	70	3	26267537
Pubmed	Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.	NCOA2 NCOA3 NCOA1	3.12e-08	4	70	3	15563453
Pubmed	Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI). Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	10652338
Pubmed	Redundant enhancement of mouse constitutive androstane receptor transactivation by p160 coactivator family members.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	17950690
Pubmed	SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	17476305
Pubmed	Ontogeny of steroid receptor coactivators in the hippocampus and their role in regulating postnatal HPA axis function.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	17854779
Pubmed	Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	18511550
Pubmed	Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	12714702
Pubmed	Regulation of transcription by a protein methyltransferase.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	10381882
Pubmed	SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	12514218
Pubmed	Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	11376110
Pubmed	Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	18798693
Pubmed	Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	12554772
Pubmed	SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	9812974
Pubmed	The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	10757795
Pubmed	Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.	NCOA2 NCOA3 NCOA1	7.79e-08	5	70	3	10803578
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 HAUS6 UBAP2 RNF2 RBBP6 UBAP2L MATR3 TNRC6B ZNF318 QSER1	1.50e-07	549	70	10	38280479
Pubmed	A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.	NCOA2 NCOA3 NCOA1	1.55e-07	6	70	3	16373399
Pubmed	Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines.	NCOA2 NCOA3 NCOA1	1.55e-07	6	70	3	12630920
Pubmed	Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells.	NCOA2 NCOA3 NCOA1	1.55e-07	6	70	3	16728408
Pubmed	Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.	NCOA2 NCOA3 NCOA1	1.55e-07	6	70	3	16923966
Pubmed	Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption.	NCOA2 NCOA3 NCOA1	2.72e-07	7	70	3	21195347
Pubmed	BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.	NCOA2 NCOA3 NCOA1	2.72e-07	7	70	3	16860316
Pubmed	The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.	NCOA2 NCOA3 NCOA1	2.72e-07	7	70	3	9192892
Pubmed	Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells.	NCOA2 NCOA3 NCOA1	2.72e-07	7	70	3	11117530
Pubmed	The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine.	NCOA2 NCOA3 NCOA1	2.72e-07	7	70	3	12709428
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA3 SP1 RBBP6 UBAP2L ZNF644 SIPA1L1 MATR3 OTUD4 FAM76B SCAF11 ZNF318	4.05e-07	774	70	11	15302935
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	UBAP2 RBBP6 UBAP2L ZNF644 MATR3 AGFG1 FAM76B MLLT6 SCAF11 ZNF318 QSER1 CWC22	4.18e-07	954	70	12	36373674
Pubmed	The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.	NCOA2 NCOA3 NCOA1	4.34e-07	8	70	3	12082103
Pubmed	Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities.	NCOA2 NCOA3 NCOA1	4.34e-07	8	70	3	11050077
Pubmed	Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.	NCOA2 NCOA3 NCOA1	4.34e-07	8	70	3	11971985
Pubmed	Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.	NCOA2 NCOA3 NCOA1	4.34e-07	8	70	3	12145209
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA2 NCOA3 NCOA1	4.34e-07	8	70	3	23178929
Pubmed	Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.	NCOA2 NCOA3 NCOA1	6.50e-07	9	70	3	15184363
Pubmed	Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.	NCOA2 NCOA3 NCOA1	6.50e-07	9	70	3	15888456
Pubmed	Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.	NCOA2 NCOA3 NCOA1	9.28e-07	10	70	3	15001550
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 HAUS6 MATR3 TNRC6B PLEKHA1 ZNF318 ZDHHC8	1.04e-06	263	70	7	34702444
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 CCP110 ARHGAP32 HIVEP2 UBAP2 DOCK11 SIPA1L1 MATR3 SIPA1L3 AGFG1 PLEKHA1	1.15e-06	861	70	11	36931259
Pubmed	Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.	NCOA2 NCOA3 NCOA1	1.27e-06	11	70	3	11704662
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NCOA3 NCOA1	1.27e-06	11	70	3	36613751
Pubmed	Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation.	NCOA2 NCOA3 NCOA1	1.27e-06	11	70	3	16109736
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RLF HMBOX1 NCOA2 RALGAPA1 HIVEP2 UBAP2L ATXN7L1 SIPA1L3 KCNMA1 TNRC6B RTN3 SCAF11 CHD2 QSER1	1.33e-06	1489	70	14	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIRREL3 UBAP2L ZNF644 SIPA1L1 OTUD4 TNRC6B RUBCN ZEB2	1.65e-06	407	70	8	12693553
Pubmed	The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.	NCOA2 NCOA3 AGFG1 NCOA1	1.75e-06	43	70	4	26487511
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RLF NCOA2 EPC2 NCOA3 DOCK8 ZNF644 FAM76B NCOA1 MLLT6 ZNF318 QSER1 ZEB2	1.90e-06	1103	70	12	34189442
Pubmed	Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.	NCOA2 NCOA3 NCOA1	2.20e-06	13	70	3	19255064
Pubmed	Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.	NCOA2 NCOA3 NCOA1	2.20e-06	13	70	3	11266503
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SP1 ARHGAP32 UBAP2 RBBP6 IPCEF1 AGFG1 MLLT6 HRNR	2.47e-06	430	70	8	35044719
Pubmed	Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.	SMG8 HAUS6 UBAP2 UBAP2L TNRC6B	2.59e-06	107	70	5	30995489
Pubmed	Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.	NCOA2 NCOA3 NCOA1	2.80e-06	14	70	3	11500849
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RALGAPA1 CCP110 DOCK11 DOCK8 SIPA1L1 SIPA1L3 TNRC6B PLEKHA1	3.24e-06	446	70	8	24255178
Pubmed	Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.	NCOA2 NCOA3	3.99e-06	2	70	2	21220509
Pubmed	Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Distinct Entity Characterized by Recurrent NCOA2/3 Gene Fusions.	NCOA2 NCOA3	3.99e-06	2	70	2	30273195
Pubmed	SRC-1 and TIF2 control energy balance between white and brown adipose tissues.	NCOA2 NCOA1	3.99e-06	2	70	2	12507421
Pubmed	The coactivator SRC-1 is an essential coordinator of hepatic glucose production.	NCOA3 NCOA1	3.99e-06	2	70	2	21109193
Pubmed	LPS depletes PHLPP levels in macrophages through the inhibition of SP1 dependent transcriptional regulation.	SP1 PHLPP1	3.99e-06	2	70	2	28322791
Pubmed	Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor.	NCOA3 NCOA1	3.99e-06	2	70	2	16141356
Pubmed	Immunohistochemical localization of steroid receptor coactivators in chondrosarcoma: an in vivo tissue microarray study.	NCOA3 NCOA1	3.99e-06	2	70	2	24875297
Pubmed	Impaired social behaviors and minimized oxytocin signaling of the adult mice deficient in the N-methyl-d-aspartate receptor GluN3A subunit.	OXTR GRIN3A	3.99e-06	2	70	2	29554474
Pubmed	A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.	NCOA2 NCOA3	3.99e-06	2	70	2	30048685
Pubmed	Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction.	NCOA2 NCOA1	3.99e-06	2	70	2	15070739
Pubmed	Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance.	NCOA3 NCOA1	3.99e-06	2	70	2	16459312
Pubmed	Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.	NCOA2 NCOA1	3.99e-06	2	70	2	11897715
Pubmed	Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness.	NCOA2 NCOA1	3.99e-06	2	70	2	15231721
Pubmed	Distinct steady-state nuclear receptor coregulator complexes exist in vivo.	NCOA2 NCOA1	3.99e-06	2	70	2	9751728
Pubmed	Sipa1l3/SPAR3 is targeted to postsynaptic specializations and interacts with the Fezzin ProSAPiP1/Lzts3.	SIPA1L1 SIPA1L3	3.99e-06	2	70	2	26364583
Pubmed	UBAP2/UBAP2L regulate UV-induced ubiquitylation of RNA polymerase II and are the human orthologues of yeast Def1.	UBAP2 UBAP2L	3.99e-06	2	70	2	35633597
Pubmed	lingerer, a Drosophila gene involved in initiation and termination of copulation, encodes a set of novel cytoplasmic proteins.	UBAP2 UBAP2L	3.99e-06	2	70	2	12524348
Pubmed	Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis.	NCOA2 NCOA1	3.99e-06	2	70	2	25148457
Pubmed	Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis.	NCOA2 NCOA3	3.99e-06	2	70	2	26040939
Pubmed	Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.	NCOA3 SP1 NCOA1	4.29e-06	16	70	3	15831516
Pubmed	Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action.	NCOA2 NCOA3 NCOA1	4.29e-06	16	70	3	10882104
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOA2 NCOA3 NCOA1	5.20e-06	17	70	3	19183483
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 NCOA3 SP1 ARHGAP32 MXRA5 RNF2 OTUD4 NCOA1 CHD2	5.34e-06	638	70	9	31182584
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOA2 NCOA3 SP1 UBAP2L PCDH11X NCOA1	7.77e-06	233	70	6	37704626
Pubmed	The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription.	NCOA2 NCOA3 NCOA1	8.69e-06	20	70	3	16957778
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA2 NCOA3 NCOA1	8.69e-06	20	70	3	11877444
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	HMBOX1 EPC2 SP1 YAF2 RNF2 RBBP6 ZNF644 MATR3 SCAF11 CHD2 ZNF318 QSER1	9.68e-06	1294	70	12	30804502
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA2 NCOA3 NCOA1	1.01e-05	21	70	3	19596656
Interaction	CRX interactions	RLF NCOA2 EPC2 NCOA3 SP1 ZNF644 NCOA1 MLLT6 QSER1 ZEB2	1.73e-08	254	70	10	int:CRX
Interaction	YWHAH interactions	NCOA2 RALGAPA1 CCP110 NCOA3 ARHGAP32 HIVEP2 UBAP2 YAF2 DOCK11 SIPA1L1 MATR3 SIPA1L3 KCNMA1 AGFG1 NCOA1 PLEKHA1 CWC22 RUBCN	2.57e-08	1102	70	18	int:YWHAH
Interaction	SP7 interactions	NCOA2 EPC2 NCOA3 YAF2 RNF2 RBBP6 NCOA1 ZNF318 QSER1 ZEB2	9.39e-08	304	70	10	int:SP7
Interaction	MYOD1 interactions	NCOA2 NCOA3 SP1 YAF2 ZNF644 NCOA1 FIGLA ZEB2	3.62e-07	194	70	8	int:MYOD1
Interaction	YWHAG interactions	TAOK2 RALGAPA1 CCP110 ARHGAP32 HIVEP2 UBAP2 DOCK11 SIPA1L1 MATR3 SIPA1L3 KCNMA1 AGFG1 RTN3 PLEKHA1 SCAF11 CWC22 RUBCN	8.93e-07	1248	70	17	int:YWHAG
Interaction	EGR2 interactions	NCOA2 NCOA3 HIVEP2 ZNF644 NCOA1 QSER1 ZEB2	2.14e-06	171	70	7	int:EGR2
Interaction	FMR1 interactions	HMBOX1 NCOA2 NCOA3 SMG8 UBAP2 RBBP6 UBAP2L MATR3 KCNMA1 OTUD4 TNRC6B	2.23e-06	536	70	11	int:FMR1
Interaction	TBXT interactions	NCOA2 NCOA3 YAF2 ZNF644 QSER1 ZEB2	3.10e-06	116	70	6	int:TBXT
Interaction	PAX6 interactions	RLF HMBOX1 NCOA3 YAF2 RNF2 ZNF644 MLLT6 QSER1 ZEB2	4.77e-06	366	70	9	int:PAX6
Interaction	HNF4A interactions	NCOA2 EPC2 NCOA3 SP1 ZNF644 NCOA1 QSER1 ZEB2	4.93e-06	275	70	8	int:HNF4A
Interaction	YWHAQ interactions	RALGAPA1 CCP110 NCOA3 ARHGAP32 HIVEP2 UBAP2 YAF2 DOCK11 SIPA1L1 MATR3 SIPA1L3 KCNMA1 AGFG1 NCOA1 PLEKHA1	5.35e-06	1118	70	15	int:YWHAQ
Interaction	FEV interactions	RLF NCOA2 NCOA3 RNF2 ZNF644 QSER1 ZEB2	6.65e-06	203	70	7	int:FEV
Interaction	MIER2 interactions	IL16 RNF2 ZNF644 ZNF318	8.08e-06	37	70	4	int:MIER2
Interaction	YWHAZ interactions	RALGAPA1 CCP110 ARHGAP32 HIVEP2 YAF2 DOCK11 ZNF644 SIPA1L1 MATR3 SIPA1L3 KCNMA1 OTUD4 PLEKHA1 SCAF11 HRNR RUBCN	8.84e-06	1319	70	16	int:YWHAZ
Interaction	KLF3 interactions	RLF EPC2 YAF2 RNF2 ZNF644 QSER1 ZEB2	1.42e-05	228	70	7	int:KLF3
Interaction	GARNL3 interactions	RALGAPA1 SIPA1L1 SIPA1L3	1.42e-05	14	70	3	int:GARNL3
Interaction	SMG7 interactions	NCOA2 NCOA3 UBAP2L OTUD4 NCOA1 TNRC6B MLLT6 ZNF318	1.45e-05	319	70	8	int:SMG7
Interaction	CNOT9 interactions	CCP110 HAUS6 UBAP2 UBAP2L OTUD4 TNRC6B ZNF318	1.54e-05	231	70	7	int:CNOT9
Interaction	KLF8 interactions	RLF NCOA2 EPC2 NCOA3 SP1 ZNF644 QSER1 ZEB2	1.81e-05	329	70	8	int:KLF8
Interaction	ODF2 interactions	CCP110 SP1 HAUS6 SIPA1L1 SIPA1L3 TNRC6B	1.83e-05	158	70	6	int:ODF2
Interaction	AFDN interactions	TAOK2 HORMAD2 ARHGAP32 SIPA1L1 SIPA1L3 TNRC6B PLEKHA1 MLLT6	1.98e-05	333	70	8	int:AFDN
Interaction	LATS1 interactions	CCP110 MTMR14 SIPA1L1 MATR3 SIPA1L3 OTUD4 TNRC6B PLEKHA1 CHD2	2.08e-05	440	70	9	int:LATS1
Interaction	YWHAE interactions	TAOK2 RALGAPA1 ARHGAP32 HIVEP2 YAF2 DOCK11 DOCK8 SIPA1L1 MATR3 SIPA1L3 MTMR2 KCNMA1 PLEKHA1 SCAF11 RUBCN	2.14e-05	1256	70	15	int:YWHAE
Interaction	GRIN2B interactions	TAOK2 ARHGAP32 IL16 UBAP2 GRIN3A ZEB2	2.77e-05	170	70	6	int:GRIN2B
Interaction	RNF214 interactions	SMG8 UBAP2 UBAP2L OTUD4 TNRC6B	3.08e-05	104	70	5	int:RNF214
Interaction	TLX1 interactions	NCOA2 NCOA3 RNF2 ZNF644 QSER1 ZEB2	3.26e-05	175	70	6	int:TLX1
Interaction	PAX8 interactions	NCOA2 NCOA3 ZNF644 QSER1 ZEB2	4.21e-05	111	70	5	int:PAX8
Interaction	TLE3 interactions	NCOA2 NCOA3 HIVEP2 RBBP6 OTUD4 NCOA1 MLLT6 ZNF318	4.69e-05	376	70	8	int:TLE3
Interaction	NR2F1 interactions	NCOA2 NCOA3 SP1 NCOA1	4.91e-05	58	70	4	int:NR2F1
Interaction	HNF1B interactions	HMBOX1 NCOA2 NCOA3 MLLT6 QSER1 ZEB2	5.16e-05	190	70	6	int:HNF1B
Interaction	B4GALT2 interactions	CCP110 SMG8 ARHGAP32 HAUS6 ZNF318	5.88e-05	119	70	5	int:B4GALT2
Interaction	KANK2 interactions	NCOA2 NCOA3 IL16 UBAP2 PHLPP1 NCOA1 TNRC6B	5.89e-05	285	70	7	int:KANK2
Interaction	GATA2 interactions	NCOA3 YAF2 RNF2 ZNF644 QSER1 ZEB2	6.67e-05	199	70	6	int:GATA2
Interaction	VDR interactions	NCOA2 NCOA3 SP1 OTUD4 NCOA1	8.01e-05	127	70	5	int:VDR
Interaction	CEBPA interactions	RLF NCOA2 EPC2 NCOA3 DOCK8 ZNF644 MATR3 FAM76B NCOA1 MLLT6 ZNF318 QSER1 GRIN3A ZEB2	8.12e-05	1245	70	14	int:CEBPA
Interaction	UNK interactions	SMG8 UBAP2 UBAP2L MATR3 MTMR2 OTUD4 TNRC6B MLLT6	8.31e-05	408	70	8	int:UNK
Interaction	ESRRA interactions	NCOA2 NCOA3 SP1 NCOA1	8.67e-05	67	70	4	int:ESRRA
Interaction	ZC3H7A interactions	SMG8 HAUS6 UBAP2 UBAP2L OTUD4 TNRC6B	1.02e-04	215	70	6	int:ZC3H7A
Interaction	RPGRIP1L interactions	CCP110 HAUS6 SIPA1L1 SIPA1L3 TNRC6B ZNF318	1.31e-04	225	70	6	int:RPGRIP1L
Interaction	SYNE3 interactions	TAOK2 CCP110 ARHGAP32 SIPA1L1 SIPA1L3 TNRC6B RTN3 ZNF318	1.49e-04	444	70	8	int:SYNE3
Interaction	CPEB1 interactions	UBAP2 UBAP2L MATR3 OTUD4 TNRC6B	1.54e-04	146	70	5	int:CPEB1
Interaction	SMC5 interactions	UBAP2 RBBP6 UBAP2L ZNF644 MATR3 AGFG1 FAM76B MLLT6 SCAF11 ZNF318 QSER1 CWC22	1.55e-04	1000	70	12	int:SMC5
Interaction	FOXJ2 interactions	NCOA2 RNF2 ZNF644 QSER1	1.81e-04	81	70	4	int:FOXJ2
Interaction	SOX7 interactions	NCOA2 NCOA3 NCOA1 ZEB2	1.90e-04	82	70	4	int:SOX7
Interaction	KCNA3 interactions	NCOA2 RALGAPA1 ARHGAP32 HAUS6 IL16 RBBP6 UBAP2L SIPA1L1 TNRC6B PLEKHA1 CHD2	1.93e-04	871	70	11	int:KCNA3
Interaction	EYA4 interactions	NCOA2 NCOA3 MTMR14 NCOA1 TNRC6B QSER1	1.99e-04	243	70	6	int:EYA4
Interaction	IL17RA interactions	TAOK2 SMG8 IL16 ZNF644 ZNF318	2.04e-04	155	70	5	int:IL17RA
Interaction	PGR interactions	NCOA2 NCOA3 SP1 NCOA1	2.09e-04	84	70	4	int:PGR
Interaction	CPEB4 interactions	ARHGAP32 UBAP2 UBAP2L OTUD4 TNRC6B	2.10e-04	156	70	5	int:CPEB4
Interaction	SASS6 interactions	CCP110 HAUS6 SIPA1L1 SIPA1L3 TNRC6B	2.30e-04	159	70	5	int:SASS6
Interaction	RXRA interactions	NCOA2 NCOA3 SP1 MATR3 NCOA1	3.05e-04	169	70	5	int:RXRA
Interaction	CALM1 interactions	CCP110 SP1 YAF2 RNF2 DOCK11 MATR3 KCNMA1 SCAF11 QSER1	3.05e-04	626	70	9	int:CALM1
Interaction	SIRT6 interactions	SMG8 CELSR1 UBAP2 CELSR3 DOCK11 UBAP2L ZNF644 MATR3 ZNF318	3.12e-04	628	70	9	int:SIRT6
Interaction	MED23 interactions	HMBOX1 NCOA2 EPC2 RNF2 TNRC6B CWC22	3.23e-04	266	70	6	int:MED23
Interaction	SOX17 interactions	NCOA2 NCOA3 ZNF644 HRNR	3.35e-04	95	70	4	int:SOX17
Interaction	KLF6 interactions	EPC2 SP1 ATXN7L1 ZNF644	3.35e-04	95	70	4	int:KLF6
Interaction	RORA interactions	NCOA2 SP1 NCOA1	3.35e-04	39	70	3	int:RORA
Interaction	TNIK interactions	TAOK2 ARHGAP32 DOCK11 SIPA1L1 MATR3 KCNMA1 ZEB2	3.52e-04	381	70	7	int:TNIK
Interaction	CEP135 interactions	CCP110 ARHGAP32 HAUS6 SIPA1L1 SIPA1L3 TNRC6B	3.64e-04	272	70	6	int:CEP135
Interaction	TEAD1 interactions	RLF RNF2 ZNF644 NCOA1 ZEB2	3.67e-04	176	70	5	int:TEAD1
Interaction	NR5A2 interactions	NCOA2 NCOA3 NCOA1	3.89e-04	41	70	3	int:NR5A2
Interaction	ZFP36 interactions	ARHGAP32 UBAP2L OTUD4 TNRC6B ZEB2	4.17e-04	181	70	5	int:ZFP36
Interaction	ALG13 interactions	NCOA2 NCOA3 UBAP2L OTUD4 TNRC6B	4.39e-04	183	70	5	int:ALG13
Interaction	CPSF6 interactions	TAOK2 RBBP6 UBAP2L MTMR2 PHLPP1 SCAF11 ZNF318 CWC22	4.66e-04	526	70	8	int:CPSF6
Interaction	GATA3 interactions	NCOA3 SP1 YAF2 RNF2 MLLT6	4.84e-04	187	70	5	int:GATA3
Interaction	SMAP2 interactions	UBAP2 UBAP2L AGFG1 OTUD4 TNRC6B	5.08e-04	189	70	5	int:SMAP2
Interaction	KLF15 interactions	NCOA2 EPC2 NCOA3 ZNF644 NCOA1 QSER1	5.11e-04	290	70	6	int:KLF15
Interaction	EN1 interactions	HMBOX1 YAF2 QSER1 ZEB2	5.84e-04	110	70	4	int:EN1
Interaction	SULT1C4 interactions	CCP110 SMG8 ARHGAP32 HAUS6	5.84e-04	110	70	4	int:SULT1C4
Interaction	AR interactions	NCOA2 NCOA3 SP1 RNF2 UBAP2L MATR3 NCOA1 ZNF318 TNS4 QSER1 HRNR	5.85e-04	992	70	11	int:AR
Interaction	UBAP2L interactions	TAOK2 UBAP2 UBAP2L OTUD4 PHLPP1 TNRC6B	5.89e-04	298	70	6	int:UBAP2L
Interaction	RALGAPA2 interactions	RALGAPA1 SIPA1L1 SIPA1L3	6.21e-04	48	70	3	int:RALGAPA2
Interaction	NR1I3 interactions	NCOA2 NCOA3 NCOA1	6.21e-04	48	70	3	int:NR1I3
Interaction	NR1I2 interactions	NCOA2 NCOA3 NCOA1	6.21e-04	48	70	3	int:NR1I2
Interaction	SFN interactions	RALGAPA1 CCP110 ARHGAP32 DOCK11 SIPA1L1 MATR3 SIPA1L3 PLEKHA1 TNS4	6.31e-04	692	70	9	int:SFN
Interaction	BCOR interactions	SP1 YAF2 RNF2 UBAP2L SCAF11 QSER1	6.32e-04	302	70	6	int:BCOR
Interaction	WWTR1 interactions	NCOA2 HAUS6 IL16 UBAP2 TNRC6B ZNF318 QSER1	6.47e-04	422	70	7	int:WWTR1
Interaction	PPARG interactions	NCOA2 NCOA3 SP1 DOCK11 NCOA1 MLLT6	6.89e-04	307	70	6	int:PPARG
Interaction	RNF43 interactions	ARHGAP32 HAUS6 MATR3 TNRC6B PLEKHA1 ZNF318 ZDHHC8	6.93e-04	427	70	7	int:RNF43
Interaction	MAGEA10 interactions	NCOA2 MAGEB10 QSER1	7.00e-04	50	70	3	int:MAGEA10
Interaction	YWHAB interactions	RALGAPA1 CCP110 ARHGAP32 YAF2 DOCK11 SIPA1L1 MATR3 SIPA1L3 KCNMA1 RTN3 PLEKHA1	7.02e-04	1014	70	11	int:YWHAB
Interaction	RBM47 interactions	UBAP2 RNF2 UBAP2L OTUD4 TNRC6B	7.18e-04	204	70	5	int:RBM47
Interaction	FXR2 interactions	HMBOX1 UBAP2 RNF2 UBAP2L OTUD4 TNRC6B RTN3	7.22e-04	430	70	7	int:FXR2
Interaction	PPARD interactions	NCOA2 NCOA3 SMG8 NCOA1	7.36e-04	117	70	4	int:PPARD
Interaction	YTHDF2 interactions	SMG8 UBAP2 RNF2 UBAP2L OTUD4 TNRC6B	7.49e-04	312	70	6	int:YTHDF2
Interaction	NFIC interactions	RLF NCOA3 ZNF644 SCAF11 ZEB2	8.18e-04	210	70	5	int:NFIC
Interaction	ETS1 interactions	NCOA3 SP1 RBBP6 NCOA1	8.35e-04	121	70	4	int:ETS1
Interaction	MEF2C interactions	NCOA2 NCOA3 SP1	8.77e-04	54	70	3	int:MEF2C
Interaction	PAX7 interactions	NCOA3 YAF2 RNF2 ZNF644	9.15e-04	124	70	4	int:PAX7
Interaction	KIF20A interactions	RALGAPA1 RNF2 RBBP6 UBAP2L MATR3 CNTNAP4 PHLPP1 TNRC6B CHD2 ZNF318 ZEB2	9.49e-04	1052	70	11	int:KIF20A
Interaction	NEDD1 interactions	CCP110 HAUS6 ZNF644 SCAF11 HERPUD2	1.03e-03	221	70	5	int:NEDD1
Interaction	RAC1 interactions	ARHGAP42 RALGAPA1 NCOA3 ARHGAP32 DOCK11 DOCK8 SIPA1L3 AGFG1 PLEKHA1 QSER1 ZDHHC8	1.03e-03	1063	70	11	int:RAC1
Interaction	MEX3B interactions	SMG8 UBAP2 UBAP2L OTUD4 TNRC6B	1.05e-03	222	70	5	int:MEX3B
Interaction	HDAC4 interactions	SP1 DOCK11 UBAP2L SIPA1L1 MATR3 KCNMA1 OTUD4 TNRC6B ZEB2	1.05e-03	744	70	9	int:HDAC4
Interaction	R3HDM2 interactions	UBAP2 UBAP2L OTUD4 TNRC6B	1.06e-03	129	70	4	int:R3HDM2
Interaction	ERG interactions	NCOA2 NCOA3 RNF2 MATR3 QSER1	1.07e-03	223	70	5	int:ERG
Interaction	PAX9 interactions	NCOA2 NCOA3 ZNF644 QSER1	1.09e-03	130	70	4	int:PAX9
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 NCOA3 NCOA1	1.16e-05	17	48	3	486
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3	2.07e-05	3	48	2	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3	2.07e-05	3	48	2	1189
GeneFamily	Basic helix-loop-helix proteins	NCOA2 NCOA3 NCOA1 FIGLA	2.05e-04	110	48	4	420
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR14 MTMR2	7.09e-04	15	48	2	903
GeneFamily	CD molecules\|Mucins	MUC12 MUC6	1.40e-03	21	48	2	648
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOA3 TNRC6B	1.99e-03	25	48	2	775
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DOCK11 IPCEF1 PHLPP1 PLEKHA1	2.15e-03	206	48	4	682
GeneFamily	Phosphoinositide phosphatases	MTMR14 MTMR2	3.25e-03	32	48	2	1079
GeneFamily	PDZ domain containing	IL16 SIPA1L1 SIPA1L3	7.64e-03	152	48	3	1220
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP42 ARHGAP32	7.80e-03	50	48	2	721
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	RALGAPA1 NCOA3 HAUS6 IL16 HIVEP2 DOCK11 DOCK8 RBBP6 IPCEF1 ZNF644 MATR3 AGFG1 OTUD4 NCOA1 TNRC6B PCNX1 MLLT6 SCAF11 CHD2 HERPUD2 ZEB2	1.22e-10	1492	69	21	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	RLF NCOA2 NCOA3 HIVEP2 YAF2 RNF2 SIPA1L1 AGFG1 OTUD4 PHLPP1 NCOA1 ZEB2 SEC14L1	3.13e-07	856	69	13	M4500
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	RALGAPA1 SP1 UBAP2 DOCK11 DOCK8 SIPA1L1	8.08e-06	180	69	6	M8239
Coexpression	TBK1.DF_DN	RLF HMBOX1 NCOA3 AGFG1 TNRC6B PLEKHA1 SCAF11	1.04e-05	286	69	7	M2864
Coexpression	GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	NCOA3 HIVEP2 DOCK11 PCNX1 CHD2 HERPUD2	1.47e-05	200	69	6	M9469
Coexpression	GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP	RNF2 UBAP2L MATR3 RTN3 PLEKHA1 DMP1	1.47e-05	200	69	6	M5119
Coexpression	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	DOCK8 PLEKHA1 QSER1 HERPUD2 ZEB2 SEC14L1	1.47e-05	200	69	6	M7019
Coexpression	GSE14415_INDUCED_VS_NATURAL_TREG_UP	EPC2 YAF2 RNF2 HERPUD2 ZEB2	4.65e-05	149	69	5	M2968
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	NCOA2 RALGAPA1 DOCK8 NCOA1 TMEM213	5.12e-05	152	69	5	M39239
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN	RLF MTMR14 RBBP6 ZNF644 MATR3 NCOA1 PCNX1 SCAF11 CHD2 SEC14L1	6.92e-05	844	69	10	M41129
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	RLF HAUS6 CELSR3 RBBP6 ZNF644 MATR3 KCNMA1 QSER1 CWC22	1.11e-04	721	69	9	M10237
Coexpression	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN	NCOA3 FAM76B NCOA1 RTN3 SEC14L1	1.17e-04	181	69	5	M8662
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	NCOA3 HIVEP2 OTUD4 PHLPP1 SCAF11 ZNF318	1.40e-04	300	69	6	M8702
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	RLF CCP110 SP1 AGFG1 OTUD4 ZEB2	1.40e-04	300	69	6	M14151
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL	ARHGAP42 NCOA2 ARHGAP32 RBBP6 SCAF11	1.58e-04	193	69	5	M6813
Coexpression	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	ATXN7L1 ZNF644 SIPA1L3 HERPUD2 ZEB2	1.61e-04	194	69	5	M7313
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL	ARHGAP42 NCOA2 ARHGAP32 RBBP6 SCAF11	1.69e-04	196	69	5	MM667
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	NCOA3 CELSR1 RNF2 TNRC6B PLEKHA1 PCNX1 SCAF11 CHD2 ZEB2 SEC14L1	1.70e-04	942	69	10	M8144
Coexpression	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	NCOA3 HIVEP2 IPCEF1 FAM76B HERPUD2	1.82e-04	199	69	5	M1746
Coexpression	GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP	DOCK11 IPCEF1 SIPA1L1 PCNX1 HERPUD2	1.86e-04	200	69	5	M9447
Coexpression	GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	EPC2 SP1 SIPA1L1 NCOA1 HERPUD2	1.86e-04	200	69	5	M301
Coexpression	GSE21063_WT_VS_NFATC1_KO_BCELL_DN	EPC2 SP1 HIVEP2 YAF2 ZNF318	1.86e-04	200	69	5	M8261
Coexpression	GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP	DOCK11 ATXN7L1 IPCEF1 AGFG1 RTN3	1.86e-04	200	69	5	M8468
Coexpression	GSE40273_GATA1_KO_VS_WT_TREG_DN	NCOA3 DOCK11 PHLPP1 NCOA1 CHD2	1.86e-04	200	69	5	M9133
Coexpression	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	NCOA3 HIVEP2 IPCEF1 FAM76B HERPUD2	1.86e-04	200	69	5	MM1033
Coexpression	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	RALGAPA1 EPC2 HAUS6 OTUD4 HERPUD2	1.86e-04	200	69	5	M6102
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	NCOA3 CELSR1 RNF2 NCOA1 TNRC6B PLEKHA1 PCNX1 CHD2 SEC14L1	1.97e-04	778	69	9	M17915
Coexpression	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	HMBOX1 RALGAPA1 MXRA5 ATXN7L1 AGFG1	3.27e-04	226	69	5	M11238
Coexpression	ZHENG_BOUND_BY_FOXP3	NCOA3 HIVEP2 RBBP6 FAM76B TNRC6B CHD2 HERPUD2	3.35e-04	498	69	7	M1741
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	NCOA2 RALGAPA1 CELSR3 SIPA1L1 SIPA1L3 PCDH11X KCNMA1 CNTNAP4 OTUD4 TNRC6B GRIN3A ZEB2	1.15e-05	818	69	12	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	HMBOX1 CCP110 EPC2 SMG8 RNF2 SIPA1L1 MATR3 RTN3 CHD2 HERPUD2	2.13e-05	595	69	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	ARHGAP42 NCOA2 RALGAPA1 CELSR1 ATXN7L1 SIPA1L1 SIPA1L3 PCDH11X CNTNAP4 OTUD4 GRIN3A	5.38e-05	806	69	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	RLF NCOA3 SP1 DOCK11 PCDH11X SCAF11 CHD2 ZEB2	5.68e-05	413	69	8	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500	RLF DOCK11 PCDH11X CHD2 ZEB2	1.79e-04	161	69	5	gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	NCOA3 DOCK11 PCDH11X CHD2 ZEB2	1.84e-04	162	69	5	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	RLF NCOA3 SP1 DOCK11 UBAP2L MATR3 PCDH11X SCAF11 CHD2 ZEB2	2.58e-04	804	69	10	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	RLF NCOA3 SP1 DOCK11 UBAP2L MATR3 SCAF11 CHD2 ZNF318 ZEB2	2.63e-04	806	69	10	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500	NCOA3 DOCK11 PCDH11X CHD2 ZEB2	2.63e-04	175	69	5	gudmap_developingGonad_e14.5_ epididymis_500_k4
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	DOCK11 DOCK8 SIPA1L1 KCNMA1 AGFG1 PCNX1 MUC6 ZEB2	7.76e-10	194	70	8	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RLF RALGAPA1 ZNF644 TNRC6B PCNX1 CHD2 ZEB2	1.91e-08	188	70	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	LV-08._Macrophage\|World / Chamber and Cluster_Paper	DOCK11 DOCK8 SIPA1L1 KCNMA1 AGFG1 MUC6 ZEB2	2.13e-08	191	70	7	e7a0bc46ba9ba772636a583f3387748418e18832
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	DOCK11 DOCK8 SIPA1L1 KCNMA1 AGFG1 MUC6 ZEB2	2.21e-08	192	70	7	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	DOCK11 DOCK8 SIPA1L1 KCNMA1 AGFG1 MUC6 ZEB2	2.21e-08	192	70	7	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	DOCK11 DOCK8 SIPA1L1 KCNMA1 AGFG1 MUC6 ZEB2	2.29e-08	193	70	7	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	RA-08._Macrophage\|World / Chamber and Cluster_Paper	DOCK8 SIPA1L1 KCNMA1 AGFG1 PCNX1 MUC6 ZEB2	2.29e-08	193	70	7	5fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	DOCK11 DOCK8 SIPA1L1 KCNMA1 AGFG1 MUC6 ZEB2	2.37e-08	194	70	7	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARHGAP42 NCOA2 SP1 RBBP6 ZNF644 SCAF11	4.85e-07	186	70	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	DOCK8 SIPA1L1 KCNMA1 AGFG1 MUC6 ZEB2	6.39e-07	195	70	6	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ARHGAP32 SIPA1L3 KCNMA1 NCOA1 TNRC6B	7.19e-07	199	70	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL3 OXTR CNTNAP4 GRIN3A DMP1	3.67e-06	148	70	5	4d43efee96a6493abd78e9ca41aab73db0c80626
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARHGAP32 SIPA1L1 MATR3 PLEKHA1 ZNF318	7.00e-06	169	70	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOCK11 DOCK8 KCNMA1 GRIN3A ZEB2	8.07e-06	174	70	5	d5c22b43531414951666ee7542a66ed9380e2d14
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 DOCK8 IPCEF1 PHLPP1 PCNX1	8.29e-06	175	70	5	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	HMBOX1 PHLPP1 TNRC6B MLLT6 CHD2	8.76e-06	177	70	5	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 CELSR1 DOCK11 DOCK8 IPCEF1	1.14e-05	187	70	5	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK11 DOCK8 AGFG1 MUC6 ZEB2	1.20e-05	189	70	5	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA2 SIPA1L1 MATR3 PCNX1 ZEB2	1.33e-05	193	70	5	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ARHGAP32 SIPA1L1 SIPA1L3 NCOA1	1.51e-05	198	70	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HAUS6 DOCK11 DOCK8 RBBP6 ZEB2	1.51e-05	198	70	5	93cc01d91ffc543fd1a717ef47e02e532b50b665
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HAUS6 DOCK11 DOCK8 RBBP6 ZEB2	1.54e-05	199	70	5	5b6feacb0ca92c3fc6b327be978320426dcf6f68
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK11 DOCK8 IPCEF1 KCNMA1 ZEB2	1.58e-05	200	70	5	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK11 DOCK8 IPCEF1 KCNMA1 ZEB2	1.58e-05	200	70	5	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	facs-Brain_Non-Myeloid-Hippocampus\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCP110 MATR3 RTN3 PLEKHA1 ZEB2	1.58e-05	200	70	5	fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c
ToppCell	Control-Control-Lymphocyte-T/NK-dn_T\|Control / Disease, condition lineage and cell class	IL16 HIVEP2 CELSR3 IPCEF1 NCOA1	1.58e-05	200	70	5	10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK11 DOCK8 IPCEF1 KCNMA1 ZEB2	1.58e-05	200	70	5	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK11 DOCK8 IPCEF1 KCNMA1 ZEB2	1.58e-05	200	70	5	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK11 DOCK8 IPCEF1 KCNMA1 ZEB2	1.58e-05	200	70	5	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK11 DOCK8 IPCEF1 KCNMA1 ZEB2	1.58e-05	200	70	5	33036d21c1c82109284473a515c4f890b33fdd5c
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DOCK8 ZNF644 SCAF11 CHD2 ZEB2	1.58e-05	200	70	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OXTR DOCK11 PCDH11X GRIN3A	3.26e-05	115	70	4	ac73aa06e617ed791c6ae9e38189bac74188c27b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL3 OXTR CNTNAP4 GRIN3A	4.38e-05	124	70	4	298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL3 OXTR PCDH11X GRIN3A	4.66e-05	126	70	4	28fbe63f7bc628b32d8e86bf9e80657e776dd1cc
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL3 OXTR PCDH11X GRIN3A	4.66e-05	126	70	4	a4fc7ac4931d2fc8aa8196a62d809b698937aa9c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL3 OXTR PCDH11X GRIN3A	6.83e-05	139	70	4	fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RALGAPA1 PCNX1 CHD2 ZEB2	8.48e-05	147	70	4	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL3 OXTR PCDH11X GRIN3A	1.04e-04	155	70	4	79264ff283e36a059040a5aa9fe7337be694cb52
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MATR3 PCNX1 ZNF318 RUBCN	1.04e-04	155	70	4	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OXTR DOCK11 PCDH11X GRIN3A	1.21e-04	161	70	4	bf70be1de418615b5442ec684552551edaf1f072
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	RALGAPA1 TNRC6B PCNX1 CHD2	1.23e-04	162	70	4	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	MXRA5 KCNMA1 GRIN3A DMP1	1.26e-04	163	70	4	c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e
ToppCell	Frontal_cortex\|World / BrainAtlas - Mouse McCarroll V32	IPCEF1 SIPA1L1 CWC22 ZEB2	1.29e-04	164	70	4	e09291711abf8680e78170328313719092b0142f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 IPCEF1 TNS4 TMEM213	1.45e-04	169	70	4	4b3a7b4a497178799b6b2f0b744f5fb752cee31a
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN7L1 NCOA1 PCNX1 TNS4	1.52e-04	171	70	4	a474aaed3ca4cacb0ab565c35f25d92a10f531b7
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MATR3 PCNX1 ZNF318 RUBCN	1.52e-04	171	70	4	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP42 SP1 HAUS6 ZDHHC8	1.66e-04	175	70	4	b4f01e7782cdd107d0817ef601891fd3a382bc35
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP42 SP1 HAUS6 ZDHHC8	1.66e-04	175	70	4	ef6f811d8e1839f405c3b41090ddf79be57a099f
ToppCell	droplet-Fat-Bat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP42 SP1 HAUS6 ZDHHC8	1.66e-04	175	70	4	7f7598d46d10bff1cbea42f950bdde1aaa16e9a4
ToppCell	NS-moderate-d_0-4-Myeloid-pDC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HMBOX1 DOCK11 RUBCN ZEB2	1.73e-04	177	70	4	de1ffe3df76100d46ca158bdd2fea2ebbd4656b4
ToppCell	Control-Lymphoid-B\|World / Disease state, Lineage and Cell class	NCOA3 SIPA1L3 TNRC6B RUBCN	1.89e-04	181	70	4	9124f1a610cfc3355ad87921cd3eb5346956475d
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA3 SIPA1L3 TNRC6B RUBCN	2.01e-04	184	70	4	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA3 SIPA1L3 TNRC6B RUBCN	2.01e-04	184	70	4	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	Control-Lymphoid-B\|Control / Disease state, Lineage and Cell class	NCOA3 SIPA1L3 TNRC6B RUBCN	2.01e-04	184	70	4	de0294f879268bfd68e91adcc2adba211d221b7a
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK8 MATR3 SCAF11 ZEB2	2.01e-04	184	70	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	NCOA3 SIPA1L3 TNRC6B RUBCN	2.05e-04	185	70	4	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	Control-Myeloid-Macrophage_Alveolar\|World / Disease state, Lineage and Cell class	DOCK11 DOCK8 KCNMA1 RTN3	2.05e-04	185	70	4	85cb81759589a26d83676cffbf2bc37399683c10
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 DOCK11 DOCK8 IPCEF1	2.10e-04	186	70	4	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARHGAP32 HIVEP2 IPCEF1 KCNMA1	2.10e-04	186	70	4	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KCNMA1 AGFG1 CNTNAP4 ZEB2	2.10e-04	186	70	4	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	IL16 DOCK8 IPCEF1 TNRC6B	2.14e-04	187	70	4	ba822dbceb47257129d6a8c9639c08d76de6d6a3
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HIVEP2 MATR3 TNRC6B PCNX1	2.14e-04	187	70	4	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK8 SIPA1L1 RUBCN ZEB2	2.18e-04	188	70	4	3be2d50148daa4eddddc2c7f269f45c97f7e4931
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CELSR1 DOCK11 IPCEF1 SIPA1L3	2.18e-04	188	70	4	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	Control\|World / Disease state, Lineage and Cell class	SIPA1L1 KCNMA1 AGFG1 ZEB2	2.23e-04	189	70	4	fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DOCK8 TNRC6B PCNX1 ZEB2	2.23e-04	189	70	4	2c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	NCOA3 SIPA1L1 SIPA1L3 RUBCN	2.27e-04	190	70	4	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	human_hepatoblastoma-Inflammatory_Monocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	DOCK11 DOCK8 KCNMA1 ZEB2	2.32e-04	191	70	4	3b59bfc6c106ae8a3fbcd4a74bd128c485724921
ToppCell	Control-Myeloid\|Control / group, cell type (main and fine annotations)	DOCK11 DOCK8 KCNMA1 ZEB2	2.32e-04	191	70	4	9c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|lung / Disease (COVID-19 only), tissue and cell type	DOCK11 DOCK8 KCNMA1 ZEB2	2.32e-04	191	70	4	dab953682b8c9ed680a799161f837f792a7e4f33
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK11 DOCK8 KCNMA1 ZEB2	2.36e-04	192	70	4	bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KIRREL3 MXRA5 DOCK11 CNTNAP4	2.36e-04	192	70	4	d88753b200d9c8da6716222d697ddf0a1548d6c8
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IL16 MXRA5 DOCK8 KCNMA1	2.36e-04	192	70	4	3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	IL16 DOCK8 IPCEF1 SCAF11	2.36e-04	192	70	4	69758a256386a6ed3a6e2c94c55d59baa34892d7
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ATXN7L1 IPCEF1 SIPA1L1 TNRC6B	2.36e-04	192	70	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 KCNMA1 AGFG1 ZEB2	2.41e-04	193	70	4	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	Control-Myeloid-Monocyte-derived_macrophages\|Control / group, cell type (main and fine annotations)	DOCK11 DOCK8 KCNMA1 ZEB2	2.41e-04	193	70	4	a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 KCNMA1 AGFG1 ZEB2	2.41e-04	193	70	4	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	DOCK11 DOCK8 KCNMA1 ZEB2	2.46e-04	194	70	4	f09675cd472200363c458952f00d2e41990800ee
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCOA3 IL16 RUBCN ZEB2	2.46e-04	194	70	4	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	CV-Severe-6\|Severe / Virus stimulation, Condition and Cluster	RBBP6 NCOA1 HERPUD2 ZEB2	2.46e-04	194	70	4	d33be6ed1de907aeea0c2dce09796556b8efdd4e
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK11 DOCK8 KCNMA1 ZEB2	2.46e-04	194	70	4	69cf7c989ac355c459db13f9d4267b55adc3c174
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CELSR1 IPCEF1 SIPA1L3 PLEKHA1	2.46e-04	194	70	4	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 SIPA1L1 KCNMA1 ZEB2	2.46e-04	194	70	4	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	SIPA1L1 KCNMA1 PCNX1 ZEB2	2.46e-04	194	70	4	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	PBMC-Mild-cDC_1\|Mild / Compartment, Disease Groups and Clusters	NCOA3 DOCK8 TNRC6B SCAF11	2.51e-04	195	70	4	674355ca00314bde90ef7f6ddb83afe2d5323130
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 SIPA1L1 KCNMA1 ZEB2	2.51e-04	195	70	4	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	human_hepatoblastoma-Inflammatory_Monocytes\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	DOCK11 DOCK8 KCNMA1 ZEB2	2.51e-04	195	70	4	ba7f85e5307d96ac5ad7c952f8d094db9ca1790c
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	DOCK8 SIPA1L1 KCNMA1 ZEB2	2.51e-04	195	70	4	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	Immune-alveolar_macrophage_(MARCO_positive)\|World / Lineage, Cell type, age group and donor	DOCK11 DOCK8 KCNMA1 ZEB2	2.51e-04	195	70	4	f92114ef995e690a3bedc62c89c5fd6773d0d9f7
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HIVEP2 TNRC6B MLLT6 CHD2	2.51e-04	195	70	4	4bdedd924564a260841a9153604026b57487c83d
ToppCell	Control-Myeloid\|Control / Disease state, Lineage and Cell class	SIPA1L1 KCNMA1 AGFG1 ZEB2	2.51e-04	195	70	4	46ce2e403ca5d757e5ba17349b6c7ce5cde1f195
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	DOCK8 SIPA1L1 KCNMA1 ZEB2	2.51e-04	195	70	4	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)\|Adult / Lineage, Cell type, age group and donor	DOCK11 DOCK8 KCNMA1 ZEB2	2.51e-04	195	70	4	55e25f702af19146a161861cfd15f40bbda1dc35
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 SIPA1L1 SIPA1L3 NCOA1	2.56e-04	196	70	4	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	MATR3 AGFG1 PCNX1 RUBCN	2.56e-04	196	70	4	15397ec27167bb2fb6fec120b68bf38fc71b2670
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK11 DOCK8 KCNMA1 ZEB2	2.56e-04	196	70	4	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	Adult-Immune-monocyte-D122\|Adult / Lineage, Cell type, age group and donor	DOCK8 SIPA1L1 KCNMA1 ZEB2	2.56e-04	196	70	4	16b0acb6157534938ca83d4e909471e33a7d3c52
ToppCell	COVID-19-Myeloid-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	DOCK8 SIPA1L1 KCNMA1 ZEB2	2.56e-04	196	70	4	4929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK11 DOCK8 PCNX1 ZEB2	2.61e-04	197	70	4	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
Drug	butamben	NCOA2 NCOA3 NCOA1	5.53e-07	6	70	3	ctd:C004605
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	TAOK2 NCOA2 RALGAPA1 SP1 SIPA1L3 PCNX1 QSER1	2.55e-06	198	70	7	1002_UP
Drug	2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3	NCOA2 NCOA3 NCOA1	4.51e-06	11	70	3	ctd:C061137
Drug	dihydroxy-vitamin D3	NCOA2 NCOA3 NCOA1	7.79e-06	13	70	3	ctd:C118756
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 NCOA3 HIVEP2 SIPA1L1 PHLPP1 NCOA1	1.45e-05	171	70	6	7535_DN
Drug	ferutinin	NCOA2 NCOA3 NCOA1	1.51e-05	16	70	3	CID000354654
Drug	Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; HL60; HT_HG-U133A	TAOK2 NCOA2 RALGAPA1 NCOA3 SP1 RNF2	3.04e-05	195	70	6	2187_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; HL60; HT_HG-U133A	NCOA2 NCOA3 HIVEP2 CELSR3 NCOA1 SEC14L1	3.04e-05	195	70	6	2468_DN
Drug	Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A	TAOK2 NCOA2 RALGAPA1 RBBP6 KCNMA1 QSER1	3.13e-05	196	70	6	4724_UP
Drug	Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	NCOA2 SIPA1L1 PCNX1 DMP1 RUBCN SEC14L1	3.13e-05	196	70	6	2530_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	TAOK2 HIVEP2 MTMR2 PHLPP1 NCOA1 ZNF318	3.13e-05	196	70	6	1662_DN
Drug	Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; HL60; HT_HG-U133A	TAOK2 RALGAPA1 SIPA1L1 NCOA1 DMP1 RUBCN	3.31e-05	198	70	6	2580_DN
Drug	Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A	NCOA3 ARHGAP32 HIVEP2 SIPA1L3 MTMR2 NCOA1	3.40e-05	199	70	6	7148_DN
Disease	prostate carcinoma, type 2 diabetes mellitus	HAUS6 UBAP2 TNRC6B	3.47e-04	59	68	3	EFO_0001663, MONDO_0005148
Disease	disease progression measurement	HORMAD2 CELSR1 HIVEP2	3.83e-04	61	68	3	EFO_0008336
Disease	autism spectrum disorder (implicated_via_orthology)	TAOK2 ARHGAP32 CNTNAP4 CHD2	4.27e-04	152	68	4	DOID:0060041 (implicated_via_orthology)
Disease	gastric ulcer (implicated_via_orthology)	OXTR MUC6	4.68e-04	14	68	2	DOID:10808 (implicated_via_orthology)
Disease	prostate cancer (is_marker_for)	NCOA2 NCOA3 PHLPP1 NCOA1	4.71e-04	156	68	4	DOID:10283 (is_marker_for)
Disease	severe acute respiratory syndrome, COVID-19	NCOA2 KIRREL3 MXRA5 PCDH11X MTMR2 KCNMA1	5.79e-04	447	68	6	EFO_0000694, MONDO_0100096
Disease	hip circumference	RALGAPA1 KIRREL3 MXRA5 DOCK8 FAM76B	1.11e-03	338	68	5	EFO_0005093
Disease	Neurodevelopmental Disorders	DOCK8 TNRC6B CHD2	1.31e-03	93	68	3	C1535926
Disease	amyloid-beta measurement	KIRREL3 FAM76B NCOA1 CHD2 CWC22	1.37e-03	355	68	5	EFO_0005194
Disease	heart rate	CELSR1 RBBP6 SIPA1L1 KCNMA1	1.83e-03	225	68	4	EFO_0004326
Disease	Hirschsprung Disease	CELSR3 ZEB2	2.33e-03	31	68	2	C0019569
Disease	Antihypertensive use measurement	ARHGAP42 HIVEP2 PLEKHA1 ZNF318	3.30e-03	265	68	4	EFO_0009927
Disease	Tinnitus	SIPA1L1 TNRC6B ZNF318	3.40e-03	130	68	3	HP_0000360
Disease	hypospadias	SP1 KCNMA1	3.67e-03	39	68	2	EFO_0004209
Disease	cortical thickness	NCOA2 SP1 CELSR1 MTMR2 TNRC6B ZNF318 FIGLA QSER1	3.98e-03	1113	68	8	EFO_0004840
Disease	Neoplastic Cell Transformation	SP1 PHLPP1 ZEB2	4.10e-03	139	68	3	C0007621
Disease	chronotype measurement	EPC2 KIRREL3 RBBP6 IPCEF1 FAM76B TNRC6B ZNF318	4.15e-03	882	68	7	EFO_0008328
Disease	revision of total hip arthroplasty, aseptic loosening	CELSR1 PHLPP1	4.25e-03	42	68	2	EFO_0010725, EFO_0020973

Protein segments in the cluster

Peptide	Gene	Start	Entry
LNSFSSSSQTIDFSS	EPC2	481	Q52LR7
SSASSSSHHEASTQE	MLLT6	276	P55198
QASFSSSSELSSSHG	CNTNAP4	41	Q9C0A0
QSSSYASSHSSDSED	CELSR1	2816	Q9NYQ6
NSISSSTSSNHSGHT	ATXN7L1	406	Q9ULK2
AFSSHSSGSQSQKFS	OTUD4	391	Q01804
SSSFASSTHCQTLQN	QSER1	521	Q2KHR3
SSAATRNSHSSATAS	OR7A5	261	Q15622
TSGTSQAHSSFSTNK	MUC6	1506	Q6W4X9
TSQTHSSFSTATASS	MUC6	2071	Q6W4X9
QQGAHSALSSASTSS	MATR3	66	P43243
SALSSASTSSHNLQS	MATR3	71	P43243
EAQSTSTSATAASHT	MAGEB10	66	Q96LZ2
ANHLSLDASSSSSSS	KCNMA1	31	Q12791
RSSSSSSSNHSDNFF	MTMR14	511	Q8NCE2
DSHSSSTSFESGTNN	HORMAD2	136	Q8N7B1
SDSSSISSHSSASAN	CWC22	701	Q9HCG8
ASSSTATASTQTQHS	HMBOX1	81	Q6NT76
ASSVQSAHQFSSDSS	PCNX1	611	Q96RV3
SAHQFSSDSSSSTTS	PCNX1	616	Q96RV3
AHSTASHSSSNSEDT	PDZK1P1	386	A8MUH7
SSSYGEQNSDSHQSS	HRNR	176	Q86YZ3
LNSSTDSAASASAAS	IL16	1206	Q14005
SVDSLSSASTSHSEN	MTMR2	21	Q13614
SSHSNSSSSSLTEKD	FAM76B	151	Q5HYJ3
ASLDHSSSSQAQASA	PCDH11X	1156	Q9BZA7
SNSSSFVLSHRSSSQ	OXTR	366	P30559
NSSSQEGLQSHSSSA	DMP1	426	Q13316
AIHSSSADATSSSNY	ARHGAP32	1426	A7KAX9
TRSHSSSASSAESQD	RBBP6	1711	Q7Z6E9
SSTLDSLFSSLHSSN	GRIN3A	551	Q8TCU5
ASSTSQSGLSNSSHN	FAM126A	356	Q9BYI3
NSLSSDDTSSLSSNH	IPCEF1	271	Q8WWN9
SSLESSFTLNHSSTT	DOCK11	1371	Q5JSL3
SISSQNSSSCSSFQD	DOCK8	1126	Q8NF50
EDSSLHSNASSHSAS	CHD2	11	O14647
ADSLHTSNSNSSGFT	CCP110	731	O43303
HLSFNSSSSSEANFK	HAUS6	786	Q7Z4H7
ASSSHHSQSSSQNSD	KIRREL3	751	Q8IZU9
ALASSSNSSSDHSGS	HERPUD2	106	Q9BSE4
SYSNNSSESHTSSAR	FIGLA	136	Q6QHK4
ASFNSSALSSVQSSS	CELSR3	3251	Q9NYQ7
TASCQSHSSNAESSS	RUBCN	336	Q92622
SHSSNAESSSSNLFS	RUBCN	341	Q92622
AESSSSNLFSSSSSQ	RUBCN	346	Q92622
HSGFSQLSAATTSSS	SEC14L1	691	Q92503
QLSAATTSSSQSHSS	SEC14L1	696	Q92503
SSGNTSSSSHSKASN	SCAF11	1336	Q99590
SSHCSNASTHSNQEA	RNF2	176	Q99496
NASSSSSSHSSTEGL	nan	391	A6NNC1
SFHIDSSSSSSSGQL	SMG8	391	Q8ND04
AATQSHSISSSSFGA	RTN3	6	O95197
SLSSHSSEQNSTTKS	ARHGAP42	636	A6NI28
QQSSDLHSSSHSNSS	NCOA1	421	Q15788
LHSSSHSNSSNSQGS	NCOA1	426	Q15788
HSFSSSSLSALQAIS	NCOA3	516	Q9Y6Q9
YSSHSSSNTLSSNAS	SIPA1L1	1281	O43166
SSNTLSSNASSAHSD	SIPA1L1	1286	O43166
NSTFSINDAASHTST	SIPA1L1	1411	O43166
SSHSSSNTLSSNASS	SIPA1L3	1266	O60292
SNTLSSNASSSHSDD	SIPA1L3	1271	O60292
ASSQSSSVNSLADAS	TAOK2	361	Q9UL54
VSSQASSSSFFTNAN	SP1	311	P08047
SSSADFGTFNTSQSH	AGFG1	291	P52594
SSTGNSHSYTNSSLN	NCOA2	521	Q15596
SASSHQSSATFSTAA	UBAP2	731	Q5T6F2
EANLHSSSSTFSTTS	UBAP2L	726	Q14157
SSDLISSDSHSDSFS	RALGAPA1	901	Q6GYQ0
NSDSNSSDQLSHSSS	RLF	891	Q13129
SLLHSSNSSHQSSSR	TNS4	291	Q8IZW8
SAASADQHSQSGSSS	YAF2	141	Q8IY57
ASSLNSLHLFSSSSN	ZNF644	766	Q9H582
TSSSSLQADQASSNA	ZDHHC8	641	Q9ULC8
AASSSSSSSAAAASH	PHLPP1	136	O60346
LNLSSTSSKNSHSSS	ZEB2	786	O60315
TNAATATSHSTASRS	PLEKHA1	316	Q9HB21
SPSQESNLSHSSSFS	HIVEP2	966	P31629
LHSACSAEASSSNSS	TMEM213	21	A2RRL7
SAEASSSNSSSLTAH	TMEM213	26	A2RRL7
QLESFSSSTSSSQDH	ZNF318	396	Q5VUA4
SASDNSFTNVHSTSA	TNRC6B	1546	Q9UPQ9
TASSLGQQSTTFHSS	MUC12	1516	Q9UKN1
TASSLGQQSTTFHSS	MUC12	4156	Q9UKN1
SSVQSSGSFHQSSSK	MXRA5	1821	Q9NR99